Blue Granite Capital’s Eli Lilly LLY Stock Holding History

Blue Granite Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,268	Closed	-$451K	–	126
2017 Q3	$451K	Buy	+5,268	New	+$432K	0.31%	81

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Blue Granite Capital's LLY Position: Q4 2017 in Review

Blue Granite Capital sold out of Eli Lilly (LLY) in Q4 2017, closing a stake of 5,268 shares — an estimated $451K sold.

Blue Granite Capital first reported a position in LLY in Q3 2017 and held it in 1 quarter. The position peaked at $451K in Q3 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

Blue Granite Capital reported no remaining Eli Lilly position as of Q4 2017 after selling out during the quarter.
Blue Granite Capital sold 5,268 Eli Lilly shares in Q4 2017, an estimated $451K.
Blue Granite Capital first reported a position in Eli Lilly in Q3 2017 and held it in 1 quarter.
Blue Granite Capital's Eli Lilly position peaked at $451K in Q3 2017.
1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.